SERPINC1 and acute respiratory distress syndrome: When thrombin was inhibited using thrombin inhibitors, such as antithrombin III or dabigatran and specific PAR-1 antagonism, the activation of platelets was significantly inhibited (Figures 6B, C), suggesting a key role for thrombin in the activation of platelets by ARDS plasma.